When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. 3 Biotech Stocks Up on Intellia's CRISPR Therapy Study Data - AOL

   www.aol.com/news/3-biotech-stocks-intellias...

   Intellia (NTLA) announces first-ever, promising clinical data on an in vivo CRISPR-based therapy. Stocks of CRSP, EDIT and BEAM rise on investor enthusiasm about their CRISPR-based candidates.

3. 10 Best Gene Editing Stocks To Buy - AOL

   www.aol.com/news/10-best-gene-editing-stocks...

   In this article, we discuss 10 best gene editing stocks to buy. If you want to see more stocks in this selection, check out 5 Best Gene Editing Stocks To Buy. A report by The Wall Street Journal ...

4. CRISPR Gene Editing Stocks Up After Intellia's Pipeline Update

   www.aol.com/news/crispr-gene-editing-stocks...

   Shares of Intellia were up as the update on its gene-editing drugs excited investors. The news also pushed up stocks of companies making gene-editing drugs, FATE, CRSP, EDIT, using CRISPR technology.

5. Intellia Therapeutics - Wikipedia

   en.wikipedia.org/wiki/Intellia_Therapeutics

   In March 2017 Intellia and Regeneron, partners in co-developing a CRISPR-based treatment for transthyretin amyloidosis, presented data from a gene editing experiment in mice. [16] [17] By that time, University of California had lost a challenge to Broad's CRISPR patents, putting Intellia at a disadvantage relative to Editas. [16]

6. Top Gene-Editing Stocks for Long-Term Investors - AOL

   www.aol.com/news/top-gene-editing-stocks-long...

   For premium support please call: 800-290-4726 more ways to reach us

7. CRISPR Stocks: Buy or Trade? - AOL

   www.aol.com/news/crispr-stocks-buy-trade...

   Gene editing will dramatically transform medicine and life, so should you just buy-and-hold the stocks? ... Science & Tech.